BIOCRYST PHARMACEUTICALS INC
BCRX·09058V103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BCRX (BIOCRYST PHARMACEUTICALS INC) is held by 164 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($238.9M), RA CAPITAL MANAGEMENT, L.P. ($158.3M), STATE STREET CORP ($151.9M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 103 funds bought BCRX.
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Mar 24, 2026 · Activists Aug 14, 2026 · Congress Dec 15, 2025
Top Holders
Showing 1-20 of 171
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer